αβ T cell receptor germline CDR regions moderate contact with MHC ligands and regulate peptide cross-reactivity by Attaf, Meriem et al.
1Scientific RepoRts | 6:35006 | DOI: 10.1038/srep35006
www.nature.com/scientificreports
αβ T cell receptor germline CDR 
regions moderate contact with 
MHC ligands and regulate peptide 
cross-reactivity
Meriem Attaf†, Stephan J. Holland‡, Istvan Bartok* & Julian Dyson#,*
αβ T cells respond to peptide epitopes presented by major histocompatibility complex (MHC) 
molecules. The role of T cell receptor (TCR) germline complementarity determining regions (CDR1 and 
2) in MHC restriction is not well understood. Here, we examine T cell development, MHC restriction and 
antigen recognition where germline CDR loop structure has been modified by multiple glycine/alanine 
substitutions. Surprisingly, loss of germline structure increases TCR engagement with MHC ligands 
leading to excessive loss of immature thymocytes. MHC restriction is, however, strictly maintained. The 
peripheral T cell repertoire is affected similarly, exhibiting elevated cross-reactivity to foreign peptides. 
Our findings are consistent with germline TCR structure optimising T cell cross-reactivity and immunity 
by moderating engagement with MHC ligands. This strategy may operate alongside co-receptor 
imposed MHC restriction, freeing germline TCR structure to adopt this novel role in the TCR-MHC 
interface.
Conventional α β T cells are MHC ‘restricted’, using their T cell receptors (TCR) to engage with MHC class I and 
II molecules presenting peptide epitopes. Thymocyte development is dependent on recognition of self-peptides 
while T cell activation is mostly driven by non-self peptides. Two mechanisms have been proposed to underlie 
this strong ligand bias. The CD8 and CD4 T cell co-receptors have dual specificity for (i) MHC class I and II 
respectively and (ii) the intracellular proximal kinase lck1. Consequently, only when MHC ligands are engaged 
will lck be actively co-localised with the TCR/CD3 complex allowing efficient phosphorylation of CD3 ITAM 
motifs and initiating signal transduction2–5. As the co-receptor binding sites on MHC class I and II are largely 
conserved across alleles6, this indirect mechanism will impose self-MHC restriction without the need for con-
ventional ‘hardwired’ ligand specificity. Alternatively, based on conserved germline CDR residues and recurrent 
interactions between TCR and the MHC α -helices, specificity for MHC could be ‘hardwired’ and intrinsic to the 
receptor itself7,8.
Previously, using retrogenic mice, we (i) redirected in vivo VDJ recombination to randomly diversify germline 
CDR structure and (ii) used chimeric TCR-β chains with γ δ lineage germline loops to show that the germline 
CDRs are not required for recognition MHC ligands9. Rather, based on these data, we hypothesised the TCR 
adopts an antibody-like strategy for engaging MHC ligands, scanning cell surface molecules for interfaces which 
are compatible with thymic selection. Here, we confirm this antibody-like recognition by exchanging the TCRβ 
germline CDRs for immunoglobulin (Ig) heavy (H) and light (L) chain germline CDRs which direct thymic selec-
tion of both CD4 and CD8 α β T cell repertoires. These findings suggest that the TCR germline CDRs may play 
a more subtle role in ‘fine-tuning’ engagement with MHC ligands. To investigate this hypothesis, we produced 
TCR transgenic strains with structurally ‘simplified’, flexible germline CDRs through multiple glycine and alanine 
substitutions. Our analyses show that wild-type TCR structures moderate engagement with MHC to optimise T 
cell selection and peptide cross-reactivity within the peripheral T cell repertoire.
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The TCR Adopts an antibody-like strategy for ligand recognition
To directly establish whether the TCR uses an antibody-like strategy of ligand recognition, we produced retro-
genic mice expressing chimeric TCR/Ig chains composed of TRBV16 (Vβ 11) containing the germline CDR1 and 
2 regions from a heavy (H) or light (H) chain immunoglobulin V segment. The IgH and IgL germline CDRs differ 
in length and composition from TRBV16 and introduce 19 and 15 amino-acid changes respectively (Fig. 1a). To 
minimise the role of TCR-β CDR3 in ligand engagement, it was reduced to triple glycine in all constructs used in 
this work (Figs 1a and 2a)9,10. Retrogenic mice were produced in FVB/N (H2q) TCR β /δ KO mice making T cell 
development dependent on the exogenous chimeric β chain11. Both chimeric chains were able to direct the devel-
opment of mature thymocytes and peripheral T cell compartments (Fig. 1b,c) consistent with the TCR adopting 
an antibody-like strategy for ligand recognition9. Further, these findings support the hypothesis that the CD4 and 
CD8 co-receptors play a key role in imprinting MHC restriction and suggest that the germline CDR regions may 
play a secondary role in ‘fine-tuning’ TCR engagement with MHC:peptide ligands.
Figure 1. Chimeric TCR-β chains with immunoglobulin germline CDRs direct T cell selection. (a) Wild-
type BV16 TCR germline CDR1 and 2 regions are shown (top) with corresponding hybrid TCR-β chains 
containing IgHV and IgLV CDRs regions below. To minimise the role of CDR3 in ligand engagement, it  
was reduced to a triple glycine in all constructs. For identification, CDRs are boxed. Mutated amino-acids  
are highlighted. Framework residues are shown in bold. Deleted amino-acids are indicated with dots.  
(b) Retrogenic mice (n = 3 in each group) were produced with the chimeric TCR-β chains. Left panels show 
example flow cytometry plots of thymus, spleen and lymph node. Right panels show summaries of percentages 
of thymocyte populations (DN, DP, SP4, SP8) and spleen/lymph node CD4 and CD8 T cells.
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Germline TCR structure restrains ligand engagement during thymic T cell development
To explore this idea, we produced a transgenic strain expressing a mutant TRBV16 chain in which germline struc-
ture was ‘simplified’ by introducing alanine/glycine substitutions across CDR1 and CDR2 (canonical structure 
group β CDR1.2/β CDR2.212) (Fig. 2a; Δ β CDR1-3). Additionally, the semi-conserved Y56 at the start of CDR2, 
which plays a role in controlling MHC engagement7, was deleted (Fig. 2a). As for the retrogenic mice, to minimise 
the role of TCR-β CDR3 in ligand engagement, it was reduced to triple glycine (Fig. 2a). Founder Δ β CDR1-3 and 
control TRBV16 with mutated CDR3 only (Δ β CDR3; Fig. 2a) transgenic lines were also produced directly in the 
FVB/N (H2q) TCR β /δ KO strain. The remainder of this paper will focus on these two transgenic strains.
Strikingly, thymic cellularity of the Δ β CDR1-3 transgenic mice was significantly reduced in comparison to 
the control Δ CDR3 transgenic (Fig. 2b). The numbers of CD4+ CD8+ double positive (DP) thymocytes and sin-
gle positive (SP)4 and SP8 thymocytes were also significantly reduced in the Δ β CDR1-3 transgenic (Fig. 2c,d). 
The Δ β CDR1-3 phenotype is consistent with intensified ligand engagement across the DP pre-selection thy-
mocyte repertoire where the majority of negative selection occurs13. This hypothesis was examined by looking 
at markers of TCR engagement. Expression of the negative regulator of TCR signalling CD5 on DP thymocytes 
parallels the intensity of interaction between the TCR and MHC14 providing a quantitative readout of MHC 
engagement. CD5 expression on Δ β CDR1-3 DPs was significantly higher than in the control Δ CDR3 transgenic 
(Fig. 3a). Similarly, up-modulation of the TCR itself is indicative of competence to undergo positive selection15. 
Again, the Δ β CDR1-3 mutant had an increased proportion of TCRhi DP thymocytes in comparison with the 
Δ CDR3 control transgenic (Fig. 3b). TCR mean fluorescence intensity (MFI) was comparable in TCRlo cells from 
Δ β CDR3 and Δ β CDR1-3 mice (Fig. 3c). The activation marker CD69 is induced on DP thymocytes undergo-
ing positive or negative selection16 and was also expressed on an increased proportion of Δ β CDR1-3 DP thy-
mocytes (Supplementary Fig. S1). We conclude that the TCR repertoire of Δ β CDR1-3 mutant DP thymocytes 
has enhanced affinity for self-ligands identifying an unexpected role for germline TCR structure in restraining 
engagement with MHC ligands.
MHC restriction is imposed independently of germline TCR structure
Wild-type TCRs can engage with MHC and non-MHC ligands although, in the presence of the co-receptors, 
the latter are generally non-productive interactions4,5. We considered that loss of germline TCR structure could 
also promote recognition of non-MHC ligands, perhaps overriding co-receptor imposed MHC restriction and 
contributing to functional ligand engagement by the Δ β CDR1-3 TCR repertoire. To identify any such produc-
tive, non-MHC ligand engagement, the Δ β CDR1-3 mutant was crossed onto MHC deficient backgrounds. As 
previously shown17, in the absence of both MHC class I and II, few SP4/8 thymocytes (Fig. 4a,b) and peripheral 
CD4/8 T cells (Fig. 5a,b) are selected from wild-type TCR repertoires. Identical phenotypes were seen when the 
Δ β CDR1-3 mutant TCR-β was co-expressed (Figs 4b,c and 5b,c). In the absence of MHC I/II, CD5 expression 
on DP thymocytes is reduced reflecting the lack of TCR signalling14. Importantly, in this setting CD5 expression 
was expressed equivalently in the presence or absence of the Δ β CDR1-3 mutant (Fig. 6) excluding a role for 
Figure 2. TCR-β mutants and TCR ΔβCDR3 and ΔβCDR1-3 transgenic thymus phenotypes. (a) Wild-
type BV16 TCR germline CDR1 and 2 regions are shown (top) with Δ β CDR1-3 and Δ β CDR3 TCR-β mutants 
below. To minimise the role of CDR3 in ligand engagement, it was reduced to triple glycine in both constructs. 
For identification, CDRs are boxed. Mutated amino-acids are highlighted. Framework residues are shown in 
bold. Deleted amino-acids are indicated with dots. Δ β CDR1-3 & Δ β CDR3 mutants were used to produce 
transgenic mice. (b) Thymic cellularity of transgenic Δ β CDR3, Δ β CDR1-3 and FVB/N β /δ KO. (c) Example 
of Δ β CDR3 and Δ β CDR1-3 thymic CD4/CD8 profiles. (d) Summary of Δ β CDR3 (n = 9) and Δ β CDR1-3 
(n = 10) DN, DP, SP4 and SP8 cell numbers.
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non-MHC ligands in TCR signalling via Δ β CDR1-3 mutant TCRs. Individually, expression of MHC class I and 
class II gave rise exclusively to SP8/CD8 and SP4/CD4 populations respectively both in the absence and presence 
of the transgenic Δ β CDR1-3 mutant (Figs 4a–c and 5a–c). Despite Δ β CDR1-3 expression being lower than 
endogenous TCR in this cross, possibly due to co-expression with endogenous TCR (Supplementary Fig. S2), its 
presence significantly increased CD5 expression in the MHC class I+/II+ and MHC I−/II+ groups (Fig. 6). These 
data demonstrate that the Δ β CDR1-3 mutant CD4 and CD8 T cell repertoires formed by pairing with endoge-
nous TCR-α chains are strictly MHC restricted.
Germline TCR structure controls peptide cross-reactivity
Given the increased engagement of the Δ β CDR1-3 repertoire with MHC ligands during development, the impact 
on peripheral T cell-mediated immunity was assessed. The peripheral Δ β CDR1-3 T cell repertoire was distinct 
from the Δ β CDR3 in having smaller CD4 and CD8 T cell populations (Fig. 7a,b) reflecting the smaller thymic 
SP4 and SP8 populations (Fig. 2b). Further, surface TCR expression was reduced (Fig. 7c,d) and proportions of 
activated CD62-L−CD44+ CD4 and CD8 T cells were increased (Fig. 7e,f). Overall, this phenotype is consistent 
with constitutive TCR engagement promoting T cell differentiation. On-going engagement with MHC ligands 
as the cause of low surface TCR expression was investigated by adoptive transfer of Δ β CDR1-3 spleen cells into 
MHC I/II sufficient (FVB/N β /δ KO) or MHC I/II deficient (B6 MHC I/II KO) recipients. Consistent with this 
explanation, surface TCR was up-modulated in the absence of MHC but remained low in MHC sufficient recip-
ients (Fig. 8).
Antigen-specific T cell responses of Δ β CDR1-3 and control Δ β CDR3 transgenic mice were assessed by IFN-γ 
elispot following immunisation with hen egg lysozyme protein (HEL). Responses were assayed on pools of 4–5 
HEL peptides showing Δ β CDR1-3 mice responded more robustly to 4/10 pools than control Δ β CDR3 mice 
(Fig. 9a). This observation prompted us to examine peptide cross-reactivity within the two repertoires. HEL 
immunised mice were assessed for recognition of peptides from the unrelated protein Epstein-Barr virus nuclear 
antigen 1 (EBNA1). Both strains responded similarly to whole HEL protein (Fig. 9b upper). Strikingly, HEL 
immunised Δ β CDR1-3, but not Δ β CDR3 mutant mice, also responded to the EBNA1 peptide pool (Fig. 9b 
lower). These data demonstrate that TCR cross-reactivity to is regulated by germline TCR structure.
Discussion
Our findings provide further evidence that germline CDRs do not hardwire the TCR for recognition of MHC 
ligands4,5,9,16,18,19. Rather, we show they have the opposite function of moderating engagement with MHC ligands. 
Figure 3. Loss of germline CDR structure increases TCR engagement with thymic ligands. (a) Left, example 
of CD5 expression on Δ β CDR3 and Δ β CDR1-3 DP thymocytes. Right, summary of CD5 mean fluorescence 
intensity (MFI) on DP thymocytes for Δ β CDR3 (n = 13) and Δ β CDR1-3 (n = 8) transgenic mice. (b) Left, 
example of TCR-β expression on Δ β CDR3 (n = 12) and Δ β CDR1-3 (n = 7) DP thymocytes. Gate indicates 
TCRlo and TCRhi populations. Right, summary of percentages of TCRlo/TCRhi DP thymocytes. (c) Summary of 
TCRβ MFI within the TCRlo and TCRhi gates.
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The Δ β CDR1-3 mutant studied here has germline CDRs with simpler, flexible loop structures through substitu-
tion of larger, complex amino-acid side-chains (H, Y, R, N, Q) for glycine and alanine. We hypothesise that the 
modified loops reduce steric hindrance effects when engaging with MHC ligands increasing the average affinity 
of the interface accounting for the increase in CD5 expression across the DP pre-selection thymocyte repertoire 
and the increased TCRhi and CD69hi components (Fig. 3, Supplementary Fig. S1). Conversely, the more complex 
and rigid20 wild-type structures will less frequently find compatible interfaces and thus enrich the repertoire with 
T cells that generally engage MHC ligands within a lower affinity range. Indeed the germline β CDR1 and 2 are 
known to undergo the smallest conformational changes on binding MHC ligands20. The moderating influence of 
germline structure on MHC engagement can likely be achieved in many ways consistent with the sequence diver-
sity of CDR1 and 2 across the α and β variable segment repertoires9 which results in substantial combinatorial 
complexity.
As thymic positive selection proceeds at extremely low affinities21, a degree of steric hindrance may offer an 
efficient solution to achieving optimal engagement across the set of highly polymorphic MHC I and II ligands. 
Indeed, chimeric TCR-β chains with γ δ T cell lineage, Ig heavy and Ig light chain CDRs are capable of produc-
tively engaging with MHC I and II9,22 (Fig. 1).
Figure 4. ΔβCDR1-3 expressing thymocytes cells are MHC restricted. Examples of thymic CD4, CD8 
profiles of mice with WT TCR (a) and WT + Δ β CDR1-3 TCR (c). Expression of MHC class I and II are 
indicated on the left. (b) Summary of data from multiple mice (n = 4–16 per group) showing percentages of SP4 
and SP8 thymocytes. Gating was set by single stain controls.
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In the context of wild-type germline structure, single amino-acid substitutions, in particular tyrosine, can 
diminish MHC engagement23. However, the same residues are also important for engagement with non-MHC lig-
ands16 and are enriched within Ig germline CDRs24 suggesting generic properties such as versatile Van der Waals 
interactions are employed to contribute to interface formation. Strikingly, loss of germline TCR structure did not 
compromise MHC restriction highlighting the efficiency of co-receptor imposed ligand bias18.
The majority of TCR:MHC:peptide co-crystals show the TCR engages MHC ligands with a fixed orientation 
and constrained geometry25 which, at least for MHC class I, can promote productive signalling26. Our findings 
do not support the idea that germline TCR structure is crucial for directing docking topology as functional 
engagement with MHC was increased in the absence of germline structure. Indeed, two TCRs derived from 
human induced T regulatory cells bound MHC class II with reversed polarity19. A mechanistic link between 
docking topology and signalling competence has been proposed to involve appropriate positioning of co-receptor 
bound lck with CD3 ITAMs27. Whether the modified Δ β CDR1-3 germline CDR loops influence docking topol-
ogy is unclear but we may infer that the germline CDRs remain MHC-centric28 rather than peptide-centric as the 
Δ β CDR1-3 peripheral repertoire is highly peptide cross-reactive, which would not be expected if self-peptides 
were strongly engaged by the germline CDRs.
Figure 5. ΔβCDR1-3 expressing peripheral T cells are MHC restricted. Examples of splenic CD4 and CD8 T 
cell profiles of mice with WT TCR (a) and WT + Δ β CDR1-3 TCR (c). (b) Summary of data from multiple mice 
(n = 4–16 per group) showing percentages of splenic CD4 and CD8 T cells. Expression of MHC class I and II are 
indicated on the left.
www.nature.com/scientificreports/
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We propose that increased engagement of MHC by Δ β CDR1-3 TCRs shifts the pre-selection repertoire 
towards negative selection (Figs 2 and 3) favoring survival of DP thymocytes whose TCR CDR3 loops make only 
limited contact with self-peptide. In similar fashion, MHC-centric Δ β CDR1-3 TCRs on peripheral T cells would 
reduce the contribution required from non-self peptide to reach the threshold for T cell activation accounting 
for their increased peptide cross-reactivity (Fig. 9). On the other hand, wild-type CDR structures, by engag-
ing less well with MHC, place greater emphasis on CDR3 engagement with peptide resulting in lower peptide 
cross-reactivity. The T cell compartment must be able to recognise virtually any peptide, this is orders of magni-
tude greater than the number of T cell clones in an individual. TCR cross-reactivity is therefore an essential fea-
ture of the T cell repertoire29; indeed, peptide cross-reactivity of several TCRs has been estimated to be typically 
> 106 28,30,31. We conclude that germline structure governs this crucial aspect of the TCR repertoire by ‘fine-tuning’ 
Figure 6. CD5 is not up-modulated by the ΔβCDR1-3 TCR in the absence of MHC. (a) Expression of 
CD5 on DP thymocytes in the absence of MHC I + II (filled plots) and presence of MHC I, MHC II and MHC 
I + II as indicated. Left plots are WT TCR and right plots are WT + Δ β CDR1-3. (b) Summary of CD5 mean 
fluorescence intensity on DP thymocytes (n = 4–16 per group).
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TCR engagement with MHC ligands. In WT TCRs, cross-reactivity is mostly due to tolerance of peptide substi-
tutions to residues outside of the TCR interface and relatively conservative changes to residues that contact the 
CDR3 loops whilst maintaining germline CDR-MHC docking28. Δ β CDR1-3 germline CDRs with simpler, flexi-
ble loop structures will have broader docking options providing a mechanism to further increase cross-reactivity.
Figure 7. Phenotype of peripheral ΔβCDR3 and ΔβCDR1-3 T cells. (a) Examples of Δ β CDR3 and 
ΔβCDR1-3 spleen CD4 and CD8 T cell populations. (b) Summary of spleen CD4 and CD8 T cell numbers 
in ΔβCDR3 (n = 15) and Δ β CDR1-3 (n = 19) transgenic mice. (c) Example of TCR beta chain expression on 
ΔβCDR3 and Δ β CDR1-3 T cells. (d) Summary of TCR mean fluorescence intensity on Δ β CDR3 (n = 14) 
and Δβ CDR1-3 (n = 9) CD4 and CD8 T cells. (e) Expression CD62-L and CD44 were used to quantify naïve 
(CD62-L+, CD44−) and activated (CD62-L−, CD44+) populations of Δ β CDR3 and Δ β CDR1-3 CD4 and CD8 
T cells. (f) Summary of percentages of naïve and activated populations in transgenic Δ β CDR3 (n = 6) and 
ΔβCDR1-3 mice (n = 7).
Figure 8. TCR on ΔβCDR1-3 T cells is down-modulated by MHC engagement. Δ β CDR1-3 splenocytes 
were adoptively transferred to C57BL/6 (MHC I/II deficient; n = 4) or FVB/N β /δ KO (MHC sufficient; n = 4) 
recipients. Both types of recipients are T cell deficient. After 14 days, TCR levels on peripheral blood CD4 and 
CD8 T cells were measured by flow cytometry. Examples of staining are shown in (a) and a summary of TCR-β 
MFI expression in (b).
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In summary, the BCR and α β TCR appear to use their germline regions in a functionally analogous manner 
to achieve their distinct strategies of antigen recognition. Co-receptor mediated sequestration of lck focuses the 
α β TCR repertoire onto MHC ligands allowing the germline regions to ‘fine-tune’ the affinity of this engagement 
and regulate peptide cross-reactivity.
Although both arms of adaptive immunity evolved in early jawed vertebrates with primitive extant species 
(cartilaginous fish) having the key components (RAG 1/2, BCR, TCR, MHC I/II, CD4 and CD8), their evolution-
ary relationship is unclear. We speculate that ‘antibody-like’ recognition of ligand by receptors of both lineages 
may have allowed variable segments to be more easily ‘co-opted’ to function as part of the alternative strategy of 
antigen recognition simplifying the early evolutionary path of adaptive immunity.
Methods
Mice. Mice were housed under specific pathogen-free conditions at Imperial College London. All experi-
mental protocols were approved by the Institutional Animal Welfare and Ethical Review Committee and the 
Home Office and were performed in accordance with the relevant guidelines and regulations. WT FVB/N 
(H2q) mice were obtained from Harlan Laboratories, Loughborough, UK. FVB/N TCR-β /δ KO were a kind gift 
from Prof. Daniel Pennington. C57BL/6 MHC class I, II deficient mice32 were a kind gift from Prof. Matthias 
Merkenschlager. TCR-β chain variants were synthesised (Mr Gene, Regensburg, Germany). Genetically modified 
mice (retrogenic and transgenic) were produced directly on an FVB/N TCR-β /δ KO background. Disruption at the 
trb locus prevents expression of endogenous TCR-β chains and α β T cell development. Developing α β T cells 
must use the exogenous TCR-β chain9,11. For retrogenic expression, TCR-β chains were cloned into the pMigR1 
retroviral vector and transduced into FVB/N TCR-β /δ KO haematopoietic stems cells (HSC) which were then 
injected intravenously into irradiated (600 Rad) FVB/N TCR-β /δ KO recipients as previously described9,11. For con-
ventional transgenic production, the T cell specific expression vector pVA-hCD233 was used which gives position 
independent expression directed by the CD2 LCR. For each transgene, two founders were produced which had 
indistinguishable phenotypes.
Figure 9. ΔβCDR1-3 T cells are highly cross-reactive. IFN-γ Elispot assays of responses by spleen cells 
harvested from mice immunised with HEL protein. Panel (a) shows that Δ β CDR1-3 mice (n = 4) respond 
robustly to a broader range of HEL-derived peptide pools (4–5 peptides) than Δ β CDR3 mice (n = 4). Panel (b) 
shows Elispot responses of HEL immunized mice [Δ β CDR3 (n = 7) and Δ β CDR1-3 mice (n = 8)] to whole 
HEL (upper) and whole EBNA1 peptide panel (lower). Each pair of bars represents a different mouse shown 
in the corresponding position in both charts. Negligible Elispot responses were seen in the absence of antigen 
(TCM; tissue culture medium only). Stimulation index (SI) for HEL and EBNA1 for each mouse was used to 
compare responses. For responses to HEL, Δ β CDR3 and Δ β CDR1-3 groups responded similarly (p = 0.93), 
while for responses to EBNA1, only the Δ β CDR1-3 group responded (p = 0.0078).
www.nature.com/scientificreports/
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To breed the Δ β CDR1-3 transgenic strain onto MHC deficient backgrounds (MHC I+ II+; MHC I+ II−; MHC 
I− II+; MHC I− II−) it was back-crossed with MHC class I, II deficient mice (H2b) and the offspring typed by flow 
cytometry for MHC I, MHC II and TRBV16 for the transgenic TCR.
Immunisation. 6 week old female mice were immunised (s.c.) by injection of 200 μ l of HEL (final concentra-
tion 7 nM) (Sigma, Poole, UK) emulsified in complete Freund’s adjuvant (CFA) and boosted after 7 days with HEL 
emulsified in incomplete Freund’s adjuvant (IFA). Mice were sacrificed after a further 7 days.
IFN-γ ELISpot immunoassay. An Elispot kit (Genprobe-Diaclone, Besançon, France) was used in accord-
ance with the manufacturer’s directions. In brief, PVDF 96-well plates (Millipore, Watford, UK) were activated 
with 70% ethanol then coated with 100 μ l of 10 μ g/ml of capture antibody overnight (4 °C) then washed 6X with 
sterile PBS. Plates were then blocked with PBS/2% powdered milk and washed. 105 responder cells were added to 
each well along with antigen and incubated overnight at 37 °C/5% CO2. Plates were then washed 6X with 100 μl 
PBS/0.1% Tween-20 and the biotinylated detection antibody added. After 2 hrs, the plates were washed 6X as 
before. 100 μ l of streptavidin-alkaline phosphatase was then added (1 hr/37 °C) and the plates developed. Spot 
forming cells were visualised using the AID ELISpot plate reader (AID Diagnostika, Germany). Antigens: HEL 
(Sigma, Poole, UK); HEL peptide pool of 24 15mers with 10 amino acid overlap (GL Biochem, Shanghai, China) 
and EBV EBNA1 peptide pool (JPT Peptide Technologies, Berlin, Germany) with 158 15mer peptides with 11 aa 
overlap.
Cell preparation. Tissues were harvested from 5–8 week old wild-type transgenic mice and from retrogenic 
mice 5–7 weeks after reconstitution. Cell suspensions were prepared using a sterile cell strainer and washed twice 
in 2 ml of phosphate-buffered saline (PBS). Blood and spleen preparations suspended for 30 minutes at room 
temperature in red blood cell lysis buffer (Qiagen, Hilden, Germany) to lyse red blood cells, centrifuged and 
resuspended as appropriate for the procedure.
Flow Cytometry. Cell suspensions were stained with fluorochrome-conjugated monoclonal antibodies 
against CD4, CD8, TCR-β constant region, TRBV16, CD44, CD62-L, CD5, CD69, MHC I, MHC II (all from 
BD Biosciences). Samples were incubated for twenty minutes at room temperature, washed in 2 ml of PBS and 
kept at 4 °C until acquisition on a BD FACSCaliburTM flow cytometer using the CellquestTM Software (BD). A live 
lymphocyte gate was applied to all samples. Further gating was done on CD4+ and CD8+ as appropriate. Data 
analysis was performed on FlowJo version 5.7 (Tree Star Inc, US).
Statistics. Inter-group variations were analysed by two-tailed, unpaired t-tests using GraphPad Prism 5. 
Results are shown graphically as mean and standard error of the mean (SEM). P values are given for 95% confi-
dence intervals.
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